Werner Brouwer
Overview
Explore the profile of Werner Brouwer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
2564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jara K, Hernandez J, Mouter N, Brouwer W, van Exel J
Soc Sci Med
. 2024 Dec;
365():117581.
PMID: 39667171
Background: The outbreak of COVID-19 was followed by an unprecedented package of measures to protect public health. Over 150 countries mandated school closures to reduce the risk of transmission. Decisions...
2.
van Hezik-Wester V, de Groot S, Kanters T, Wagner L, Ardesch J, Brouwer W, et al.
Value Health
. 2024 Aug;
27(12):1679-1688.
PMID: 39127247
Objectives: The Epilepsy Support Dog Evaluation study was commissioned by the Dutch Ministry of Health, Welfare and Sports to inform a reimbursement decision on seizure dogs. The randomized trial found...
3.
de Bruijn A, van Don M, Knies S, Brouwer W, Reckers-Droog V
Pharmacoeconomics
. 2024 May;
42(8):879-894.
PMID: 38796810
Background: The availability of increasingly advanced and expensive new health technologies puts considerable pressure on publicly financed healthcare systems. Decisions to not-or no longer-reimburse a health technology from public funding...
4.
van Hezik-Wester V, de Groot S, Kanters T, Wagner L, Ardesch J, Brouwer W, et al.
Neurology
. 2024 Feb;
102(6):e209178.
PMID: 38417090
Background And Objectives: The aim of this study was to evaluate whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog. Methods: An individual-level stepped-wedge randomized...
5.
Reckers-Droog V, Enzing J, Brouwer W
Eur J Health Econ
. 2024 Feb;
25(8):1449-1459.
PMID: 38411843
Health authorities using cost-effectiveness analysis (CEA) for informing reimbursement decisions on health technologies increasingly require economic evaluations encompassing both CEA and budget impact analysis (BIA). Good Research Practices advocate that...
6.
Mendoza-Jimenez M, van Exel J, Brouwer W
Eur J Health Econ
. 2024 Jan;
25(7):1239-1260.
PMID: 38261132
An important issue in economic evaluations is determining whether all relevant impacts are considered, given the perspective chosen for the analysis. Acknowledging that patients are not isolated individuals has important...
7.
Henry E, Al-Janabi H, Brouwer W, Cullinan J, Engel L, Griffin S, et al.
Pharmacoeconomics
. 2023 Dec;
42(3):343-362.
PMID: 38041698
Background: Omission of family and caregiver health spillovers from the economic evaluation of healthcare interventions remains common practice. When reported, a high degree of methodological inconsistency in incorporating spillovers has...
8.
Himmler S, van Exel J, Brouwer W, Neumann-Bohme S, Sabat I, Schreyogg J, et al.
Eur J Health Econ
. 2023 Oct;
25(1):187.
PMID: 37864067
No abstract available.
9.
Schawo S, Hoefman R, Reckers-Droog V, Lawerman-van de Wetering L, Kaminer Y, Brouwer W, et al.
Eur J Health Econ
. 2023 Sep;
25(5):903-913.
PMID: 37755542
Background: Systemic family interventions for adolescents with problems of substance use and/or delinquency are increasingly focused subject of economic evaluations. Treatment effects go beyond improvements in commonly measured health-related quality...
10.
Krol M, Hosseinnia N, Brouwer W, van Roijen L
Pharmacoeconomics
. 2023 Aug;
41(9):1031-1050.
PMID: 37592122
Background: Compensation mechanisms and multiplier effects may affect productivity losses due to illness, disability, or premature death of individuals. Hence, they are important in estimating productivity losses and productivity costs...